RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 1 year 18 weeks ago
Fri, 05/24/2024 - 02:00
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study 5/24/2024
Fri, 05/24/2024 - 02:00
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far? 5/24/2024
Fri, 05/24/2024 - 02:00
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data 5/24/2024
Fri, 05/24/2024 - 02:00
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss 5/24/2024
Thu, 05/23/2024 - 02:00
Takeda Joins Hot Molecular Glue Market With $1.2B Deal 5/23/2024
Thu, 05/23/2024 - 02:00
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027 5/23/2024
Thu, 05/23/2024 - 02:00
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche 5/23/2024
Thu, 05/23/2024 - 02:00
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing 5/23/2024
Thu, 05/23/2024 - 02:00
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm 5/23/2024
Thu, 05/23/2024 - 02:00
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program 5/23/2024
Thu, 05/23/2024 - 02:00
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts 5/23/2024
Thu, 05/23/2024 - 02:00
BioSpace x DIA: Navigating the Emergence of CGT Combination Products 5/23/2024
Thu, 05/23/2024 - 02:00
Do You Need to Love Your Job to Be Happy at Your Job? 5/23/2024
Tue, 05/21/2024 - 02:00
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030 5/21/2024
Tue, 05/21/2024 - 02:00
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea 5/21/2024
Tue, 05/21/2024 - 02:00
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology 5/21/2024
Tue, 05/21/2024 - 02:00
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms 5/21/2024
Tue, 05/21/2024 - 02:00
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials 5/21/2024
Tue, 05/21/2024 - 02:00
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate 5/21/2024
Tue, 05/21/2024 - 02:00
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act 5/21/2024